Dexamethasone, steroid; oral

DRUG2 trials

Sponsors

Pfizer, Array Biopharma, now a wholly owned subsidiary of Pfizer

Conditions

Multiple MyelomaMultiple Myeloma, Plasma Cell LeukemiaPlasma Cell Leukemia

Phase 1

A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma

CompletedNCT00821249

PfizerMultiple Myeloma, Plasma Cell Leukemia

Start: 2009-01-31End: 2016-03-16Updated: 2020-10-19

A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

CompletedNCT01248923

Array Biopharma, now a wholly owned subsidiary of PfizerMultiple Myeloma, Plasma Cell Leukemia

Start: 2010-12-31Updated: 2020-09-30

Related Papers

A Phase 1 and 2 study of Filanesib alone and in combination with low‐dose dexamethasone in relapsed/refractory multiple myeloma

Cancer2017-08-1772 citations